超声引导下局部甲氨蝶呤注射治疗宫颈妊娠
回顾性分析15例宫颈妊娠患者,均接受经阴道超声引导下局部甲氨蝶呤注射作为初始治疗。全部15例治疗成功,无需输血或手术;3例因血清hCG下降不佳需追加局部注射,1例因持续阴道出血及增强MRI可见血管的妊娠囊增大需子宫动脉栓塞。10例有再孕意愿者中7例后续妊娠顺利。
要点
- 经阴道超声引导下局部甲氨蝶呤注射可作为宫颈妊娠的初始保守治疗选择。
- 治疗后需监测血清hCG及超声评估妊娠囊,必要时行MRI。
- 血清hCG下降不佳可追加局部注射,持续出血或妊娠囊增大需考虑子宫动脉栓塞。
核心结论
- 单次超声引导下局部甲氨蝶呤注射对宫颈妊娠似乎有效,无需同期操作或手术干预;该保守技术保留生育功能并可能获得后续顺利妊娠。
研究设计与样本
- 回顾性研究,纳入15例宫颈妊娠患者,均接受经阴道超声引导下局部甲氨蝶呤注射作为初始治疗,治疗后监测血清hCG并行超声评估,必要时行MRI。
关键影像表现/征象
- 治疗后超声评估妊娠囊,必要时行MRI;1例增强MRI可见妊娠囊增大且内有血管。
诊断标准与关键数值
- 甲氨蝶呤注射时中位估计孕龄为6+2周(范围5+2至11+0周)。
- 治疗后血清hCG降至正常平均时间43.8天(95%CI 33.3-54.3天)。
- 月经恢复平均时间68.4天(95%CI 51.9-84.9天)。
- 15例均治疗成功,无需输血或手术;3例因血清hCG下降不佳追加局部甲氨蝶呤注射;1例因持续阴道出血及增强MRI可见血管的妊娠囊增大行子宫动脉栓塞。
临床应用与阅片要点
- 治疗后应监测血清hCG水平并用超声评估妊娠囊,必要时行MRI。
- 血清hCG下降不佳者可追加局部甲氨蝶呤注射。
- 持续阴道出血且妊娠囊增大、增强MRI可见血管者需考虑子宫动脉栓塞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Cervical pregnancy (CP) is a rare type of ectopic pregnancy. While methotrexate (MTX) is generally the first-line method of choice for clinically stable women, there is still no consensus on the most appropriate treatment for this abnormal pregnancy. The aim of this study was to investigate the efficacy of a single local MTX injection under transvaginal ultrasound guidance for the initial treatment of CP and to assess post-treatment fertility.
METHODS: We reviewed retrospectively 15 patients with CP treated with local MTX injection under transvaginal ultrasound guidance. In all patients, the serum human chorionic gonadotropin (hCG) levels were monitored and the gestational sac was evaluated using ultrasonography after treatment. Magnetic resonance imaging (MRI) was performed as necessary. We evaluated the patients' clinical characteristics and clinical course after treatment, the efficacy of the treatment and the post-treatment fertility in patients desiring subsequent pregnancy.
RESULTS: The median estimated gestational age at the time of MTX injection was 6 + 2 (range, 5 + 2 to 11 + 0) weeks. All 15 patients were treated successfully, without the need for blood transfusion or surgical procedures; however, three patients required an additional local MTX injection due to a poor decline in serum hCG level following the initial injection, while one patient required uterine artery embolization due to persistent vaginal bleeding and an enlarging gestational sac with blood vessels visible on contrast-enhanced MRI. The mean time following initial MTX injection for hCG normalization was 43.8 (95% CI, 33.3-54.3) days and for resumption of menses was 68.4 (95% CI, 51.9-84.9) days. Seven of the 10 women desiring subsequent pregnancy following treatment had uneventful pregnancy, one became pregnant but miscarried spontaneously at 8 weeks of gestation, one was treated by laparoscopic surgery after diagnosis of a tubal pregnancy and one did not conceive.
CONCLUSIONS: A single, ultrasound-guided, local MTX injection is apparently effective for the treatment of CP without the need for concomitant procedures or surgical intervention. Furthermore, this conservative technique both preserves fertility and allows for the possibility of subsequent uneventful pregnancy. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Yamaguchi M, Honda R, Erdenebaatar C, et al. Treatment of cervical pregnancy with ultrasound-guided local methotrexate injection. Ultrasound Obstet Gynecol. 2017. PMID: 27943496. doi:10.1002/uog.17384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。